Mounjaro was initially approved for diabetes, while Zepbound received FDA approval specifically for weight management
Previous studies have indicated that the GLP-1 signaling pathway is involved in regulating c-Fos expression and promoting neuronal proliferation [22,33,53], and its enhanced transmission leads to an increase in anxiety-like behaviors [26,46], while the expression of c-Fos in related brain regions is elevated [45,68,69]
Over the last 10 years, the average worker contributions for single coverage has increased 40% and the average worker contribution for family coverage increased 44% [Figures 6.4 and 6.5]
Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhoea
Your provider can help you time each phase for the best results